ask="N/A"
ask_size="N/A"
average_daily_volume="179298"
bid="N/A"
bid_size="N/A"
book_value="0.56"
change="+0.01"
change_from_200_day_moving_average="0.12"
change_from_50_day_moving_average="0.16"
change_from_52_week_high="-1.34"
change_From_52_week_low="0.63"
change_in_percent="+0.40%"
close="2.53"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.31"
ebitda="-5.76M"
eps_estimate_current_year="-0.34"
eps_estimate_next_quarter="-0.21"
eps_estimate_next_year="-0.91"
ex_dividend_date="N/A"
float_shares="16233000"
high="2.58"
high_52_weeks="3.87"
last_trade_date="1/6/2017"
last_trade_price="2.53"
last_trade_size="140"
last_trade_time="3:59pm"
low="2.52"
low_52_weeks="1.90"
market_capitalization="47.28M"
moving_average_200_day="2.41"
moving_average_50_day="2.37"
name="Brainstorm Cell Therapeutics In"
notes="N/A"
one_year_target_price="6.00"
open="2.54"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+5.14%"
percent_change_from_50_day_moving_average="+6.59%"
percent_change_from_52_week_high="-34.63%"
percent_change_from_52_week_low="+33.16%"
previous_close="2.52"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="4.48"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="18687000"
short_ratio="1.75"
stock_exchange="NCM"
symbol="BCLI"
volume="31090"
weeks_range_52="1.90 - 3.87"
